Green William Contraceptive Risk: The FDA, Depo-Provera, and the Politics of Experimental Medicine 9781479836987

Варианты приобретения

Цена: 4514.00р.
Кол-во:
Наличие: Поставка под заказ. Есть в наличии на складе поставщика.
Склад Америка: Есть
При оформлении заказа до:
Ориентировочная дата поставки:
При условии наличия книги у поставщика.

Добавить в корзину

в Мои желания

Автор: Green William
Название: Contraceptive Risk: The FDA, Depo-Provera, and the Politics of Experimental Medicine
ISBN: 9781479836987
Издательство: Mare Nostrum (Eurospan)
Классификация:

Политика центрального правительства

ISBN-10: 1479836982
Обложка/Формат: Paperback
Страницы: 336
Вес: 0.50 кг.
Дата издания: 02.05.2017
Серия: Biopolitics
Язык: English
Размер: 229 x 150 x 23
Ключевые слова: Central government policies, LAW / Administrative Law & Regulatory Practice,POLITICAL SCIENCE / Public Policy / General
Подзаголовок: The fda, depo-provera, and the politics of experimental medicine
Рейтинг:
Поставляется из: Англии
Описание: The story of Depo-Provera joins the national struggle over the drugs FDA approval to the state legal issues raised by its contraceptive and criminal justice uses. Depo-Provera is known as an injectable hormonal birth control method, but few are familiar with its dark and complicated history. Depo-Provera was tested on women since the mid-1960s without their informed consent until it was FDA-approved in 1992, but never FDA-approved as chemical castration for male sex offenders. Contraceptive Risk is William Greens landmark study of Depo-Provera. Based on a fascinating combination of archival materials and interviews, the book is framed as three interconnected stories told by Judith Weisz, who chaired the FDAs Public Board of Inquiry on Depo-Provera, a scientific court; by Anne MacMurdo who brought a products liability suit against Upjohn, the drugs manufacturer, for the deleterious side effects she suffered from the drugs use; and by Roger Gauntlett, an Upjohn heir who, when he was convicted of sexual assault, refused to take a dose of his familys own medicine as a probation condition. Together these three stories of Depo-Proveras convoluted fifty year odyssey call for a paradigm shift in pharmaceutical drug development.

Contraceptive Risk is a thoroughly researched and engrossing approach to the scientific, political and institutional forces involved in health law and policy, as well as the multifaceted politics of measuring risk.

Contraceptive Risk: The FDA, Depo-Provera, and the Politics of Experimental Medicine, Green William